Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06206239
What this trial is testing

Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma
Thomas Jefferson University 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757
What this trial is testing

Investigate APL-5125 in Adults With Advanced Solid Tumors

Who this might be right for
Colorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more
Apollo Therapeutics Ltd 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05374512
What this trial is testing

Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

Who this might be right for
Breast Cancer
AstraZeneca 644
Not applicableStudy completedNCT03292328
What this trial is testing

Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Who this might be right for
Breast CancerPeripheral NeuropathyGynecologic Cancer
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)WithdrawnNCT05539365
What this trial is testing

Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+1 more
Roswell Park Cancer Institute
Not applicableNot Yet RecruitingNCT07427407
What this trial is testing

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

Who this might be right for
Breast Cancer
AURA Health Technologies 100
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Not applicableUnknownNCT05748353
What this trial is testing

Endocrine Disruptors and Life STILe in Breast Cancer Development

Who this might be right for
Breast CancerBRCA1 MutationBRCA2 Mutation+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 275
Not applicableStudy completedNCT06826053
What this trial is testing

The Smell of Breast Milk and Therapeutic Positions in Comfort

Who this might be right for
Respiratory Distress
Karamanoğlu Mehmetbey University 70
Testing effectiveness (Phase 2)Study completedNCT00028639
What this trial is testing

PS-341 in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Not applicableLooking for participantsNCT06222957
What this trial is testing

The Effects of HER2 Receptor Signaling on Human Brown Fat Activity

Who this might be right for
Breast Cancer
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)UnknownNCT05872412
What this trial is testing

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 82
Not applicableStudy completedNCT00857012
What this trial is testing

Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)

Who this might be right for
Breast Cancer
AstraZeneca 2,313
Not applicableStudy completedNCT00233077
What this trial is testing

Patient Centered Randomized Controlled Trial

Who this might be right for
Early-Stage Breast Cancer
Icahn School of Medicine at Mount Sinai 374
Very early researchLooking for participantsNCT06008275
What this trial is testing

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Who this might be right for
Metastatic Triple-Negative Breast CarcinomaBreast Cancer
Baylor Research Institute 20
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06842472
What this trial is testing

PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02755272
What this trial is testing

Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Carcinoma Breast Stage IV
Fox Chase Cancer Center 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04430595
What this trial is testing

Multi-4SCAR-T Therapy Targeting Breast Cancer

Who this might be right for
Breast Cancer
Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT01319539
What this trial is testing

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+11 more
National Cancer Institute (NCI) 12
Next Page